HOME >> BIOLOGY >> NEWS
New designed paclitaxel analog kills more cancer cells than natural product

Blacksburg, Va., June 21, 2004 -- A multi-university research team led by Virginia Tech University Distinguished Professor of Chemistry David G. I. Kingston and his collaborators Professor Susan Bane at the State University of New York (SUNY) Binghamton and Professor James P. Snyder at Emory University has succeeded in enhancing the structure of paclitaxel (TaxolTM) to make it more effective in killing cancer cells. They did so by rational design, based on a hypothesis developed by Snyder that paclitaxel adopts a "T-shaped" conformation in its binding pocket on beta-tubulin.

This work is described in the Proceedings of the National Academy of Sciences (PNAS) online early edition the week of June 21 (www.pnas.org), in the article "The bioactive Taxol conformation on (beta)-tubulin: Experimental evidence from highly active constrained analogs," by Research Scientist Thota Ganesh, Graduate Student Rebecca C. Guza and David Kingston, all of Virginia Tech; Research Scientist Rudravajhala Ravindra, Graduate Student Natasha Shanker, and Susan Bane, all of SUNY Binghamton; and Graduate Student Ami Lakdawala and James P. Snyder of Emory, all with the chemistry departments of their respective institutions.

Paclitaxel, a natural compound from yew trees, is the world's best-selling anticancer drug. Several analogs are in clinical trial, with others in preclinical development. One problem that paclitaxel and all its analogs share, however, is that they are all highly complex compounds, and cannot be prepared synthetically in a commercially viable way. "The Holy Grail of paclitaxel research would be to find a compound that had the same biological effect as paclitaxel, but could be prepared synthetically in a few steps," said Kingston. The discovery by the cross-university team marks a significant step along the road to this objective.

Kingston explains that paclitaxel binds to tubulin, a protein mole
'"/>

Contact: Susan Trulove
strulove@vt.edu
540-231-5646
Virginia Tech
21-Jun-2004


Page: 1 2 3 4

Related biology news :

1. Newly designed nanoparticle quantum dots simultaneously target and image prostate tumors in mice
2. Beyond biology: Simple system yields custom-designed proteins
3. Novel proteins designed that block inflammation regulator associated with rheumatoid arthritis
4. Adirondack interstate underpasses designed for wildlife attract anything but, study says
5. Molecules designed to interfere with DNA upon signal
6. New potential sites for Alzheimers genes suggest a future of custom-designed treatment
7. New sensor being designed to detect, identify invisible agents faster
8. Epimmune scientists report positive pre-clinical data on vaccine designed to combat HIVs ability to mutate
9. Genetically engineered skin substitute is designed to promote wound healing
10. New paclitaxel analog kills more cancer cells than natural product
11. Vitamin D analog found to boost radiation

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/9/2019)... ... March 09, 2019 , ... Hello Bio announces the launch ... for scientists studying GPCR and DREADD signalling. Hello Bio has been granted a ... Neurological Disorders and Stroke, both institutes of the National Institutes of Health, as ...
(Date:3/1/2019)... ... March 01, 2019 , ... Geneious would like to announce it ... alternative to Vector NTI. , Geneious Prime already has a dedicated importer for ... NTI, so that files will be organised in Geneious in the same way. ...
(Date:2/27/2019)... ... February 27, 2019 , ... Fluxion Biosciences, a leading developer of precision solutions ... Cancer Institute grant for further development of its ERASE-Seq liquid biopsy technology. The Phase ... lab of Dr. Omar Mian at the Cleveland Clinic. , Liquid biopsies offer the ...
Breaking Biology News(10 mins):
(Date:3/14/2019)... ... March 14, 2019 , ... EyeCRO LLC has been awarded ... joins the Department of Veterans Affairs, the Oklahoma Medical Research Foundation, Oklahoma State ... in Oklahoma to receive this prestigious endorsement. The award letter from AAALAC ...
(Date:3/14/2019)... ... March 14, 2019 , ... ... that its Canadian partner, the Eye Machine Canada Inc., had been given approval ... technology for treating Age-Related Macular Degeneration (AMD). , The previous month, the medical ...
(Date:3/14/2019)... ... March 14, 2019 , ... ... for preclinical research organizations. It is a low code, GDPR/21 CFR Part ... facilities, innovative technology-driven automated data capture and seamless data and information management. ...
(Date:3/11/2019)... ... 11, 2019 , ... In this live webinar, the featured speakers will focus ... and experience. Participants will learn how to use the information they have from the ... simple or complex randomization scheme is properly designed and set up to ensure flawless ...
Breaking Biology Technology:
Cached News: